AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15646908 — intervention group
Group type: EXPERIMENTAL
Intervention: The Wand (computerized anesthesia delivery system)
Number of subjects: 33
Study 15646908 — intervention group
Group type: COMPARATOR
Intervention: Traditional syringe (control)
Number of subjects: 33
Study 15646908 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 33
Study 11531031 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedaling at 41 rpm
Number of subjects: 12
Study 11531031 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedaling at 63 rpm
Number of subjects: 12
Study 11531031 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedaling at 83 rpm
Number of subjects: 12
Study 11531031 — intervention group
Group type: EXPERIMENTAL
Intervention: Zero-load cycling
Number of subjects: 12
Study 11531031 — intervention group
Group type: EXPERIMENTAL
Intervention: 50-watt loaded cycling
Number of subjects: 12
Study 9434649 — intervention group
Group type: EXPERIMENTAL
Intervention: 17-minute videotape on the consequences of eating a high-fat diet
Number of subjects: 192
Study 9434649 — intervention group
Group type: COMPARATOR
Intervention: Placebo videotape on workplace management
Number of subjects: 192
Study 7852228 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 325mg (group A, n = 12)
Number of subjects: 28
Study 7852228 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 160mg (group B, n = 16)
Number of subjects: 28
Study 7852228 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (both doses)
Number of subjects: 28
Study 2508483 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (DA) infusion at 5 micrograms.kg‐1.min‐1
Number of subjects: 8
Study 2508483 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (DA) infusion at 10 micrograms.kg‐1.min‐1
Number of subjects: 8
Study 2508483 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (DA) infusion at 2.5 micrograms.kg‐1.min‐1
Number of subjects: 8
Study 1156147 — intervention group
Group type: EXPERIMENTAL
Intervention: End-to-end (Scott) or end-to-side (Payne) shunts (31 standard length shunts and 21 shortened bypasses)
Number of subjects: 52
Study 1156147 — intervention group
Group type: EXPERIMENTAL
Intervention: Shortened bypass procedures
Number of subjects: 52
Study 1156147 — intervention group
Group type: COMPARATOR
Intervention: Standard bypass procedures
Number of subjects: 52
Study 1156147 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall outcomes of jejunoileal bypass
Number of subjects: 52
Study 1156147 — intervention group
Group type: EXPERIMENTAL
Intervention: New complications reported
Number of subjects: 52
Study 31115240 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy (NA), N=26
Number of subjects: 112
Study 31115240 — intervention group
Group type: COMPARATOR
Intervention: Upfront surgery (US), N=86
Number of subjects: 112
Study 31115240 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who underwent surgery (N=96)
Number of subjects: 112
Study 30693806 — intervention group
Group type: EXPERIMENTAL
Intervention: True Electroacupuncture (EA)
Number of subjects: 51
Study 30693806 — intervention group
Group type: COMPARATOR
Intervention: Sham Electroacupuncture (SEA)
Number of subjects: 51
Study 30693806 — intervention group
Group type: COMPARATOR
Intervention: Control (no acupuncture)
Number of subjects: 51
Study 28381246 — intervention group
Group type: EXPERIMENTAL
Intervention: FIT programme (daily group handwashing with soap, toothbrushing with fluoride toothpaste, biannual school-based deworming, construction of handwashing facilities)
Number of subjects: 1847
Study 28381246 — intervention group
Group type: COMPARATOR
Intervention: Regular government health education curriculum and biannual deworming (Control)
Number of subjects: 1847
Study 24691156 — intervention group
Group type: EXPERIMENTAL
Intervention: BE-ACTIV
Number of subjects: 82
Study 24691156 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 82
Study 23414978 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based behavioral intervention for children with persistent asthma
Number of subjects: 300
Study 23414978 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 300
Study 21488935 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone substitute (Algipore(®)) alone
Number of subjects: 32
Study 21488935 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone substitute with resorbable membrane (Osseoquest(®))
Number of subjects: 32
Study 21488935 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 32
Study 16822105 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-session group cognitive-behavioral therapy (CBT)
Number of subjects: 135
Study 16822105 — intervention group
Group type: COMPARATOR
Intervention: group play therapy
Number of subjects: 135
Study 16822105 — intervention group
Group type: COMPARATOR
Intervention: general clinic comparison
Number of subjects: 135
Study 16822105 — intervention group
Group type: EXPERIMENTAL
Intervention: nonsexual offenses (all groups)
Number of subjects: 135
Study 12921807 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol CR/XL
Number of subjects: 600
Study 12921807 — intervention group
Group type: COMPARATOR
Intervention: Gly allele presence
Number of subjects: 600
Study 10512903 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen treatment (100% oxygen, 3 L/min) for 24 hours
Number of subjects: 292
Study 10512903 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional oxygen)
Number of subjects: 292
Study 10512903 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen treatment (100% oxygen, 3 L/min) for 24 hours among patients with SSS scores of >/=40
Number of subjects: 292
Study 10512903 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional oxygen) among patients with SSS scores of >/=40
Number of subjects: 292
Study 10512903 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen treatment (100% oxygen, 3 L/min) for 24 hours among patients with SSS scores of <40
Number of subjects: 292
Study 10512903 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional oxygen) among patients with SSS scores of <40
Number of subjects: 292
Study 7793298 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting plasma insulin levels in the FH group
Number of subjects: 37
Study 7793298 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting plasma insulin levels in obese FH subgroup
Number of subjects: 37
Study 7793298 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin sensitivity in the FH group
Number of subjects: 37
Study 7793298 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin sensitivity in obese FH subgroup
Number of subjects: 37
Study 7793298 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin sensitivity in non-obese FH subgroup
Number of subjects: 37
Study 7793298 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between insulin and BMI
Number of subjects: 37
Study 7793298 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal parameters including insulin
Number of subjects: 37
Study 2029134 — intervention group
Group type: EXPERIMENTAL
Intervention: Flucloxacillin alone
Number of subjects: 88
Study 2029134 — intervention group
Group type: COMPARATOR
Intervention: Combination of flucloxacillin and metronidazole
Number of subjects: 88
Study 2029134 — intervention group
Group type: COMPARATOR
Intervention: Various classic surgical wound types
Number of subjects: 88
Study 7270617 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine irrigation with cefamandole nafate solution
Number of subjects: 90
Study 7270617 — intervention group
Group type: COMPARATOR
Intervention: Intrauterine irrigation with normal saline solution
Number of subjects: 90
Study 7270617 — intervention group
Group type: COMPARATOR
Intervention: No irrigation
Number of subjects: 90
Study 6708603 — intervention group
Group type: EXPERIMENTAL
Intervention: Colestipol
Number of subjects: 16
Study 6708603 — intervention group
Group type: COMPARATOR
Intervention: Sitosterol
Number of subjects: 16
Study 6708603 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of colestipol and sitosterol
Number of subjects: 16
Study 29659416 — intervention group
Group type: EXPERIMENTAL
Intervention: PICU Soothing intervention (parental comforting with touch and reading, followed by music via soft headbands, administered once daily throughout hospitalization)
Number of subjects: 20
Study 29659416 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 20
Study 26814276 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS targeting the left DLPFC
Number of subjects: 40
Study 26814276 — intervention group
Group type: COMPARATOR
Intervention: Cathodal tDCS targeting the left DLPFC
Number of subjects: 40
Study 24525046 — intervention group
Group type: EXPERIMENTAL
Intervention: l-citrulline malate 1 g three times daily for two weeks
Number of subjects: 25
Study 22421908 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training with curcumin ingestion
Number of subjects: 45
Study 22421908 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training with placebo ingestion
Number of subjects: 45
Study 22421908 — intervention group
Group type: COMPARATOR
Intervention: Curcumin ingestion
Number of subjects: 45
Study 22421908 — intervention group
Group type: COMPARATOR
Intervention: Placebo ingestion
Number of subjects: 45
Study 20096030 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin plus gentamicin
Number of subjects: 283
Study 20096030 — intervention group
Group type: COMPARATOR
Intervention: Penicillin plus gentamicin
Number of subjects: 283
Study 17921391 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulas containing graded cystine concentrations (11, 22, 32, 43, or 65 mg cyst(e)ine/100 mL) with generous amounts of methionine.
Number of subjects: 25
Study 16133496 — intervention group
Group type: EXPERIMENTAL
Intervention: Tunnel restorations
Number of subjects: 182
Study 16133496 — intervention group
Group type: COMPARATOR
Intervention: Saucer-shaped restorations
Number of subjects: 182
Study 16133496 — intervention group
Group type: EXPERIMENTAL
Intervention: Both types of restorations
Number of subjects: 182
Study 12442066 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day in-patient education programme
Number of subjects: 76
Study 10629708 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy or hormone therapy with tamoxifen
Number of subjects: 317
Study 10629708 — intervention group
Group type: COMPARATOR
Intervention: Organ sparing treatment (sectorial resection +/‐ axillary dissection)
Number of subjects: 317
Study 7782525 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Nd: YAG laser treatment (113 mJ pulses at 15 pulses s‐1 for 3 min)
Number of subjects: 21
Study 7782525 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 21
Study 1912540 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital peripheral angiography with stepping and subtraction (DPSA)
Number of subjects: 60
Study 1912540 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital subtraction angiography without stepping (DSA)
Number of subjects: 60
Study 1912540 — intervention group
Group type: COMPARATOR
Intervention: Conventional angiography
Number of subjects: 60
Study 1912540 — intervention group
Group type: COMPARATOR
Intervention: Digital peripheral angiography without subtraction (DPA)
Number of subjects: 60
Study 7236868 — intervention group
Group type: EXPERIMENTAL
Intervention: Fencamfamine
Number of subjects: 0
Study 7236868 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 0
Study 7236868 — intervention group
Group type: COMPARATOR
Intervention: Control (no acetazolamide)
Number of subjects: 0
Study 30346026 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide (N2 O) inhalation
Number of subjects: 192
Study 30346026 — intervention group
Group type: COMPARATOR
Intervention: Local anesthesia (1% lidocaine)
Number of subjects: 192
Study 30188494 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Exposure (250 μg/m)
Number of subjects: 0
Study 30188494 — intervention group
Group type: EXPERIMENTAL
Intervention: High Exposure (500 μg/m)
Number of subjects: 0
Study 30188494 — intervention group
Group type: COMPARATOR
Intervention: Clean Air (0 μg/m)
Number of subjects: 0
Study 30188494 — intervention group
Group type: EXPERIMENTAL
Intervention: Woodsmoke (particulate matter less than 2.5 μm, PM2.5)
Number of subjects: 0
Study 30188494 — intervention group
Group type: EXPERIMENTAL
Intervention: All trials
Number of subjects: 0
Study 27980362 — intervention group
Group type: EXPERIMENTAL
Intervention: Toric orthokeratology lenses
Number of subjects: 23
Study 25315325 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal dietary and lifestyle advice
Number of subjects: 2142
Study 25315325 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 2142
Study 22162541 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-5046 (10-160 mg)
Number of subjects: 0
Study 22162541 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20306334 — intervention group
Group type: EXPERIMENTAL
Intervention: Spoon administration of Oral Rehydration Solutions (ORS)
Number of subjects: 47
Study 20306334 — intervention group
Group type: COMPARATOR
Intervention: Nasogastric tube administration of Oral Rehydration Solutions (ORS)
Number of subjects: 47
Study 20306334 — intervention group
Group type: COMPARATOR
Intervention: Both methods (spoon and nasogastric tube)
Number of subjects: 47
Study 17608314 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose methylphenidate (0.3 mg/kg/dose)
Number of subjects: 3
Study 17608314 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methylphenidate (0.5 mg/kg/dose)
Number of subjects: 3
Study 17608314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 16106488 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate (1000 mg)
Number of subjects: 33
Study 16106488 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium (900 mg)
Number of subjects: 33
Study 16106488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 12393361 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate 30 mg kg(‐1) as a bolus before induction and 10 mg kg(‐1) h(‐1) by continuous i.v. infusion during the operation
Number of subjects: 81
Study 12393361 — intervention group
Group type: COMPARATOR
Intervention: Control group (isotonic solution)
Number of subjects: 81
Study 12393361 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 81
Study 10355003 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunomodulatory treatment
Number of subjects: 0
Study 8557002 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium
Number of subjects: 0
Study 8557002 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium
Number of subjects: 0
Study 8557002 — intervention group
Group type: COMPARATOR
Intervention: Mivacurium
Number of subjects: 0
Study 1719729 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypervolaemic hemodilution using HES 200/0.5 6%
Number of subjects: 0
Study 1719729 — intervention group
Group type: EXPERIMENTAL
Intervention: Isovolaemic hemodilution using HES 200/0.5 6%
Number of subjects: 0
Study 1719729 — intervention group
Group type: COMPARATOR
Intervention: Control group (infusion of Ringer lactate)
Number of subjects: 0
Study 6813834 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Pressure (CPP)
Number of subjects: 217
Study 6813834 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Positive Pressure (IPP)
Number of subjects: 217
Study 6813834 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical Respiratory Physiotherapy
Number of subjects: 217
Study 30535860 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide pitch-window condition (anchor oddball at 850 Hz)
Number of subjects: 0
Study 30535860 — intervention group
Group type: COMPARATOR
Intervention: Narrow pitch-window condition (anchor oddball at 550 Hz)
Number of subjects: 0
Study 30442251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 30442251 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg kg‐1 S-ketamine
Number of subjects: 60
Study 30442251 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg kg‐1 S-ketamine
Number of subjects: 60
Study 27010143 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine (LMV)
Number of subjects: 1332
Study 27010143 — intervention group
Group type: EXPERIMENTAL
Intervention: Telbivudine (LdT)
Number of subjects: 1332
Study 27010143 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir Dipivoxil (ADV)
Number of subjects: 1332
Study 27010143 — intervention group
Group type: EXPERIMENTAL
Intervention: LMV + ADV
Number of subjects: 1332
Study 27010143 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir (ETV)
Number of subjects: 1332
Study 27010143 — intervention group
Group type: COMPARATOR
Intervention: Control group (LMV, ADV, LdT)
Number of subjects: 1332
Study 27010143 — intervention group
Group type: EXPERIMENTAL
Intervention: LMV + ADV and ETV
Number of subjects: 1332
Study 27010143 — intervention group
Group type: EXPERIMENTAL
Intervention: ETV
Number of subjects: 1332
Study 27010143 — intervention group
Group type: EXPERIMENTAL
Intervention: LMV
Number of subjects: 1332
Study 27010143 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 1332
Study 25277061 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen lozenges (new generic formulation by Epifarma Srl)
Number of subjects: 0
Study 25277061 — intervention group
Group type: COMPARATOR
Intervention: Benactiv Gola® (originator reference product)
Number of subjects: 0
Study 22708825 — intervention group
Group type: EXPERIMENTAL
Intervention: Fidaxomicin
Number of subjects: 1105
Study 20023215 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent rituximab (375 mg/m2) plus infusional EPOCH chemotherapy
Number of subjects: 101
Study 20023215 — intervention group
Group type: COMPARATOR
Intervention: Sequential rituximab (375 mg/m2) after completion of all chemotherapy
Number of subjects: 101
Study 17403790 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral entry pin fixation
Number of subjects: 52
Study 17403790 — intervention group
Group type: COMPARATOR
Intervention: Medial and lateral entry pin fixation
Number of subjects: 52
Study 16372229 — intervention group
Group type: EXPERIMENTAL
Intervention: hGH treatment for 24 months
Number of subjects: 19
Study 11943523 — intervention group
Group type: COMPARATOR
Intervention: 0.5% bupivacaine
Number of subjects: 30
Study 11943523 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% levobupivacaine
Number of subjects: 30
Study 9583550 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-based anesthesia
Number of subjects: 70
Study 9583550 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl-isoflurane anesthesia
Number of subjects: 70
Study 8092112 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin and lipiodol chemoembolization
Number of subjects: 20
Study 2684383 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin (DX) 75 mg/m2 IV every 3 weeks
Number of subjects: 76
Study 2684383 — intervention group
Group type: COMPARATOR
Intervention: Idarubicin (IDA) 45 mg/m2 orally every 3 weeks
Number of subjects: 76
Study 2684383 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin (DX)
Number of subjects: 76
Study 2684383 — intervention group
Group type: COMPARATOR
Intervention: Idarubicin (IDA)
Number of subjects: 76
Study 2684383 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 76
Study 30385250 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Eating and Active Living Taught at Home (HEALTH) intervention
Number of subjects: 179
Study 30385250 — intervention group
Group type: COMPARATOR
Intervention: PAT usual care
Number of subjects: 179
Study 27645465 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic manipulative therapy (CMT) - four treatments over 2 weeks
Number of subjects: 120
Study 27645465 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group - no treatment
Number of subjects: 120
Study 24239802 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgery strategy
Number of subjects: 0
Study 24239802 — intervention group
Group type: COMPARATOR
Intervention: Prolonged conservative care with surgery if needed
Number of subjects: 0
Study 24239802 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 0
Study 24239802 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in extent of VESC after 1 year
Number of subjects: 0
Study 24239802 — intervention group
Group type: COMPARATOR
Intervention: No VESC at 1 year
Number of subjects: 0
Study 24239802 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 VESC
Number of subjects: 0
Study 24239802 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 VESC
Number of subjects: 0
Study 24239802 — intervention group
Group type: EXPERIMENTAL
Intervention: Both types 1 and 2 VESC
Number of subjects: 0
Study 22302849 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose artesunate-amodiaquine regimen
Number of subjects: 0
Study 20881281 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged perineural infusion of 0.5% ropivacaine at 5 mL/h for 4 to 83 days post-surgery
Number of subjects: 71
Study 18565156 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (4 microg/kg)
Number of subjects: 321
Study 18565156 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (1, 4, or 16 microg/kg twice daily)
Number of subjects: 321
Study 18565156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 321
Study 17217744 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuezhikang (1200 mg/d)
Number of subjects: 120
Study 17217744 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 12824793 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored minimal self-help intervention (mailed self-help magazine, condom samples, condom-carrying case, booster newsletter)
Number of subjects: 1210
Study 12824793 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored minimal self-help intervention
Number of subjects: 1210
Study 12824793 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1210
Study 10629434 — intervention group
Group type: EXPERIMENTAL
Intervention: d-fenfluramine (D-FEN) 15 mg
Number of subjects: 16
Study 10629434 — intervention group
Group type: EXPERIMENTAL
Intervention: ipsapirone (IPS) 10 mg
Number of subjects: 16